HuGE Literature Finder
Records
1
-
11
Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2021 (9): e11097. Banawalikar N, Adiga S, Adiga U, Shenoy V, Kumari S, Shetty P, Shetty S, Sharmila K |
Influence of UGT2B7 and UGT1A6 polymorphisms on plasma concentration to dose ratio of valproic acid in Chinese epileptic children. Xenobiotica; the fate of foreign compounds in biological systems 2021 May 1-22. Du Zhaosong, Xu Hua, Zhao Peiwei, Wang Jing, Xu Qiong, Liu Maocha |
CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study. Epilepsy research 2021 10 177 106786. Mani Balachandran, Nair Pradeep Pankajakshan, Sekhar Anamika, Kamalanathan Sadishkumar, Narayan Sunil K, Kesavan Ramasa |
Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy. Frontiers in pediatrics 2021 2 8 599044. Xu Ze-Yue, Guo Hong-Li, Li Ling, Zhang Min, Jing Xia, Xu Ze-Jun, Qiu Jin-Chun, Lu Xiao-Peng, Ding Xuan-Sheng, Chen Feng, Xu Ji |
Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy. Therapeutic drug monitoring 2020 Feb . Zhao Mingming, Chen Yanan, Wang Minglu, Li Guofei, Zhao Lim |
Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy. European journal of clinical pharmacology 2016 Nov . Lu Yao, Fang Youxin, Wu Xunyi, Ma Chunlai, Wang Yue, Xu L |
The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach. Molecular diagnosis & therapy 2013 Oct 17 (5): 5. Munisamy M, Tripathi M, Behari M, Raghavan S, Jain DC, Ramanujam B, Arumugam K, Rajakannan T, Mallayasamy SR, Subbiah V |
Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. European journal of clinical pharmacology 2012 Oct 68 (10): 1395-401. Chu Xiao-Man, Zhang Li-Fang, Wang Guang-Ji, Zhang Shen-Ning, Zhou Jia-Hui, Hao Hai-Pi |
Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. Drug metabolism and pharmacokinetics 2012 27 (5): 536-42. Guo Yingjie, Hu Cheng, He Xiaojing, Qiu Feng, Zhao Lim |
[Effect of UGT1A6 genetic polymorphisms on the metabolism of sodium valproate]. Zhonghua yi xue za zhi 2007 Aug 87 (29): 2033-5. Sun Yan-ping, Tan Lan, Wang Yan, Song Jing-h |
Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy. Neurology India 0 63 (1): 35-9. Jain Puneet, Shastri Shivaram, Gulati Sheffali, Kaleekal Thomas, Kabra Madhulika, Gupta Neerja, Gupta Y K, Pandey Ravindra Moh |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: